Applied DNA Receives $1 Million Order to Supply SigNature® T Molecular Taggant for 2019-2020 Cotton Harvest Season
September 24 2019 - 9:00AM
Business Wire
SigNature T
taggant and its genotyping and IT complements offer traceability
and identity for cotton throughout the supply chain
Applied DNA Sciences Inc. (NASDAQ: APDN) (“Applied DNA”, the
“Company”), a leader in PCR-based DNA manufacturing for product
authenticity and traceability solutions, announced today that it
received a $1 million order to supply SigNature® T taggant for
cotton in the upcoming 2019 – 2020 ginning season which begins in
October. The Company’s SigNature T technology, paired with its
genotyping and digital systems, will be used to tag, test and track
the Pima cotton variety grown in the San Joaquin Valley, California
that is sold under the PimaCott® brand nationwide and online by the
largest home goods retailer in the U.S.
“We are pleased that the value of forensic traceability and
genotyping for cotton continues to translate to recurring demand
for tagged cotton across the home textile category,” said Dr. James
A. Hayward, president and CEO of Applied DNA. “We believe the
SigNature T platform, combined with our partner’s high standards in
supply chain quality practices, assure them brand protection and
label-claim compliance for retailers and consumers.”
The SigNature T system utilizes fully-automated DNA Transfer
Systems in the “Industrial Internet of Things” design to ensure
origin tagging process quality and as a basis for monitoring
shipments, receipts and contract compliance. In addition to our
Pima business, systems are installed in American Upland and
Egyptian varietal cotton gins. While the SigNature T analysis
confirms the traceability mark, a patented fiberTyping® analysis
confirms cotton species from fiber to finished goods. Since 2014,
and including the cotton tagged with this order, over 250 million
pounds of cotton will have been tagged as the key to a total
end-to-end traceability solution that is substantiated by forensic
test data. Over 7,000 DNA tests have been conducted on cotton
during the past five years.
About Applied DNA Sciences
Applied DNA is a provider of molecular technologies that enable
supply chain security, anti-counterfeiting and anti-theft
technology, product genotyping and isolation of circulating tumor
cells and the development of pre-clinical nucleic acid-based
therapeutic drug candidates.
Applied DNA makes life real and safe by providing innovative,
molecular-based technology solutions and services that can help
protect products, brands, entire supply chains, and intellectual
property of companies, governments and consumers from theft,
counterfeiting, fraud and diversion.
Visit adnas.com for more information. Follow us on Twitter and
LinkedIn. Join our mailing list.
Common stock listed on NASDAQ under the symbol APDN, and
warrants listed under the symbol APDNW.
Forward-Looking Statements
The statements made by Applied DNA in this press release may be
“forward-looking” in nature within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking
statements describe Applied DNA’s future plans, projections,
strategies and expectations, and are based on assumptions and
involve a number of risks and uncertainties, many of which are
beyond the control of Applied DNA. Actual results could differ
materially from those projected due to its ability to continue as a
going concern, its history of net losses, limited financial
resources, limited market acceptance, uncertainties relating to its
ability to maintain its NASDAQ listing in light of delisting
notices received and its recent hearing, and various other factors
detailed from time to time in Applied DNA’s SEC reports and
filings, including our Annual Report on Form 10-K filed on December
18, 2018, as amended and our subsequent quarterly reports on Form
10-Q filed on February 7, 2019, May 9, 2019 and August 13, 2019 and
other reports we file with the SEC, which are available at
www.sec.gov. Applied DNA undertakes no obligation to update
publicly any forward-looking statements to reflect new information,
events or circumstances after the date hereof or to reflect the
occurrence of unanticipated events, unless otherwise required by
law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190924005313/en/
Investor contact: Sanjay M. Hurry, LHA Investor
Relations, 212-838-3777, shurry@lhai.com Program contacts:
MeiLin Wan, Vice President Textile Sales, 631-240-8849,
meilin.wan@adnas.com Web: www.adnas.com Twitter:
@apdn
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Sep 2023 to Sep 2024